주메뉴 바로가기 서브메뉴 바로가기 본문 바로가기

Laboratory

> R&D > Laboratory

It leads the development of CAR treatments with a new concept of an anti-cancer immunotherapy platform for various refractory
carcinomas.

Starting with Korea's first anti-cancer immunotherapeutics for pet dogs, Vaxleukin-15, We are moving to the world's best with the more efficient Vaxleukin-15 ver2.0, and the development of exclusive treatments for other pets.

In the era of AI, we are devoted to building
a smart factory to lead the global bio industry.